Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ergocalciferol 600units/5ml oral suspension
0906040N0AADZDZ
|
Ergocalciferol | Ergocalciferol | Nutrition and Blood | No data available |
|
Ergocalciferol 7,500units/5ml oral suspension
0906040N0AADRDR
|
Ergocalciferol | Ergocalciferol | Nutrition and Blood | No data available |
|
Ergocalciferol 75,000units/5ml oral suspension
0906040N0AADNDN
|
Ergocalciferol | Ergocalciferol | Nutrition and Blood | No data available |
|
Ergocalciferol 800units/5ml oral suspension
0906040N0AAEFEF
|
Ergocalciferol | Ergocalciferol | Nutrition and Blood | No data available |
|
Ergocalciferol 900units/5ml oral liquid
0906040N0AAEGEG
|
Ergocalciferol | Ergocalciferol | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.